Elevated serum growth differentiation factor 15 in multiple system atrophy patients: A case control study

doi:10.12998/wjcc.v8.i12.2473

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5730)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

373

WORD

141

HTML

2514

Figures (1-2)

254

Tables (1-3)

233

Sum=3515

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

576

Download

1639

Sum=2215

Jun 26, 2020 (publication date) through Jul 30, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Clin Cases. Jun 26, 2020; 8(12): 2473-2483
Published online Jun 26, 2020. doi: 10.12998/wjcc.v8.i12.2473

Table 1 Clinical characteristics of multiple system atrophy patients, Parkinson disease patients and controls

	MSA	PD	Control	P value
All
Subjects, n	49	50	50	-
Age, yr	61.7 ± 7.7	61.4 ± 7.5	58.5 ± 7.5	0.077
Female/male, n	26/23	26/24	30/20	0.683
Age of onset, yr	58.7 ± 7.4	56.6 ± 7.1	-
MSA-P/MSA-C, n	30/20	-	-	-
Probable/Possible, n	31/18	-	-	-
Clinical rate scales (UMSARSII/UPDRSIII)	19.5 ± 6.4 (UMSARSII)	26.1 ± 13.2 (UPDRSIII)	- -	-
GDF15, pg/mL	1105.69 (984.24)	506.70 (346.80)	313.85 (247.76)	0.000

MSA: Multiple system atrophy; MSA-P: Multiple system atrophy-parkinsonian type; MSA-C: Multiple system atrophy-cerebellar type; PD: Parkinson disease; GDF15: Growth differentiation factor 15.

Citation: Yue T, Lu H, Yao XM, Du X, Wang LL, Guo DD, Liu YM. Elevated serum growth differentiation factor 15 in multiple system atrophy patients: A case control study. World J Clin Cases 2020; 8(12): 2473-2483
URL: https://www.wjgnet.com/2307-8960/full/v8/i12/2473.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i12.2473